OMB's proposed grantmaking rule will destabilize biomedical research, experts warn

• A proposed rule from the Office of Management and Budget to revise the federal grantmaking process is drawing widespread opposition from across multiple industries.
• Members of the medical research community warn the additional red tape will only serve to impede U.